+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Anti-Infective Agents Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type, Range, Route of Administration Indication and Distribution Channel

  • PDF Icon

    Report

  • 241 Pages
  • July 2022
  • Region: Global
  • The Insight Partners
  • ID: 5646838
UP TO OFF until Jan 15th 2023
The anti-infective agents market is expected to grow from US$ 1,35,961.03 million in 2022 to US$ 1,64,196.61 million by 2028; it is estimated to grow at a CAGR of 3.19% from 2022 to 2028.

Anti-Infectives are medications that help in preventing and treating infections, such as anti-bacterial, anti-viral, anti-fungal, and antiparasitic medications. Anti-infective therapies help in the treatment of minor infections as well as many serious infectious diseases such as tuberculosis and pneumonia. These therapies have revolutionized healthcare as they enrich and extend the life of patients suffering from all types of infectious diseases.

Chronic diseases are conditions that develop over an extended period due to a combination of genetic, physiological, environmental, and behavioral variables. The four primary categories of noncommunicable diseases (NCDs) are diabetes, cancer, chronic respiratory diseases (such as chronic obstructive pulmonary disease and asthma), and cardiovascular disorders (including heart attacks and stroke). NCDs account for 41 million annual deaths, or 71% of all fatalities worldwide, according to the WHO. Over 15 million people aged 30 to 69 die from an NCD yearly; 85% of these premature deaths occur in low- and middle-income nations. The majority of NCD deaths, or 17.9 million people per year, are caused by cardiovascular diseases, followed by malignancies (9.3 million), respiratory illnesses (4.1 million), and diabetes (1.5 million). The rising prevalence of anti-infective resistance, which has now become a global public health issue, poses a hazard to human health. Anti-bacterial, anti-viral, anti-fungal, and antiparasitic drugs are anti-infective drugs that work to prevent or treat infections. Antibiotics are chemically derived antimicrobial medications that cure and prevent bacterial illnesses by eradicating or preventing their growth. Azithromycin, clarithromycin, and erythromycin are examples of macrolides, which have historically been the main antibiotic classes and were studied for their potential role in the secondary prevention of coronary heart diseases.

Based on route of administration, the anti-infective agents market is segmented into topical, oral, IV, and others. The IV segment holds the largest share of the market in 2022. Many patients suffering from bacterial infections require treatment with an antibiotic, and the oral route of administration is the most appropriate choice. However, patients in hospital are often preferred intravenous anti-infective. Moreover, an absolute requirement for intravenous administration is high when patients cannot swallow or absorb oral antibiotics and when microbial susceptibility requires an effective agent with poor oral bioavailability. An intravenous route of administration for anti-infective is also recommended for severe life-threatening and deep-seated infections owing to concerns about not achieving adequate antibiotic concentrations at the site of infection.

Based on indication, the anti-infective agents market is segmented into HIV, tuberculosis, respiratory infection, pneumonia, and others. In 2022, the HIV segment is likely to account for the largest share of the market. HIV or human immunodeficiency virus weakens an individual’s immune system by destroying important cells that fight disease and infection. Due to various factors, including their sexual partners and risky behaviors, some groups of people in the US are more likely to contract HIV than others. The risk of getting an infection after surgery can rise due to the growing suppression of HIV on the immune system. The number of patients with HIV infection has been steadily rising in recent years. The life expectancy of HIV infection and AIDS patients has dramatically increased since the introduction of antiretroviral therapy (ART). The need for surgical care and the prevalence of surgical diseases that result from HIV infection continues to rise. Numerous immunologic abnormalities that persist despite ART successful suppression of HIV replication demonstrate the potential impact of HIV on the patient’s health.

A few key primary and secondary sources referred to while preparing the report on the anti-infective agents market are the World Health Organization (WHO), European Federation of Pharmaceutical Industries and Associations, and the CDC.


Frequently Asked Questions about the Global Anti-Infective Agents Market

What is the estimated value of the Global Anti-Infective Agents Market?

The Global Anti-Infective Agents Market was estimated to be valued at $135961.03 million in 2022.

What is the growth rate of the Global Anti-Infective Agents Market?

The growth rate of the Global Anti-Infective Agents Market is 3.1%, with an estimated value of $164196.61 million by 2028.

What is the forecasted size of the Global Anti-Infective Agents Market?

The Global Anti-Infective Agents Market is estimated to be worth $164196.61 million by 2028.

Who are the key companies in the Global Anti-Infective Agents Market?

Key companies in the Global Anti-Infective Agents Market include Abbott, Allergan Plc., Astellas Pharma Inc., Merck & Co., Inc., Bayer AG, Bristol, Myers Squibb Company, Boehringer Ingelheim International GmbH and La Roche Ltd..

Table of Contents

1. Introduction
1.1 Study Scope
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Anti-Infective Agents Market - By Type
1.3.2 Global Anti-Infective Agents Market - By Range
1.3.3 Global Anti-Infective Agents Market - By Route of Administration
1.3.4 Global Anti-Infective Agents Market - By Indication
1.3.5 Global Anti-Infective Agents Market - By Distribution Channel
1.3.6 Global Anti-Infective Agents Market - By Geography
2. Anti-Infective Agents Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Anti-infective agents Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.2.2 Europe PEST Analysis
4.2.3 Asia Pacific PEST Analysis
4.2.4 Middle East and Africa PEST Analysis
4.2.5 South and Central America PEST Analysis
4.3 Experts Opinion
5. Global Anti-Infectives Agents Market - Key Market Dynamics
5.1 Key Drivers
5.1.1 Rising Prevalence of Targeted Diseases
5.1.2 Rising Government Support for Research Activities and Clinical Trials
5.2 Market Restraints
5.2.1 Emergence of Anti-infective Drugs Resistance and Their Side Effects
5.3 Market Opportunities
5.3.1 Development of New Anti-infective Agents
5.4 Future Trends
5.4.1 Rising Investments in R&D Activities in Pharmaceutical Sector
5.5 Impact Analysis
6. Anti-Infectives Agents Market - Global Analysis
6.1 Global Anti-Infectives Agents Market Revenue Forecast and Analysis
6.1.1 Overview
6.1.2 Global Anti-infectives agents Market, By Geography - Forecast and Analysis
6.1.3 Global Anti-infectives agents Market - Market Potential Analysis, By Region
6.2 Company Analysis
6.2.1 Market Positioning of Key Players
6.2.2 Comparative Company Analysis
6.2.3 Growth Strategy Analysis
6.2.4 Performance of Key Players
6.2.5 Gilead Sciences, Inc.
7. Anti-Infectives Agents Market Analysis and Forecast to 2028 - Type
7.1 Overview
7.2 Global Anti-infectives Agents Market, by Type, 2022 & 2028 (%)
7.3 Anti-Viral
7.3.1 Overview
7.3.2 Anti-Viral Market Revenue and Forecast to 2028 (US$ Million)
7.4 Anti-Bacterial
7.4.1 Overview
7.4.2 Anti-Bacterial Market Revenue and Forecast to 2028 (US$ Million)
7.5 Anti-Fungal
7.5.1 Overview
7.5.2 Anti-Fungal Market Revenue and Forecast to 2028 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others Market Revenue and Forecast to 2028 (US$ Million)
8. Anti-Infectives Agents Market Analysis and Forecast to 2028 - Range
8.1 Overview
8.2 Global Anti-Infectives Agents Market, by Range, 2022 & 2028 (%)
8.3 Narrow Spectrum
8.3.1 Overview
8.3.2 Narrow Spectrum Market Revenue and Forecast to 2028 (US$ Million)
8.4 Broad Spectrum
8.4.1 Overview
8.4.2 Broad Spectrum Market Revenue and Forecast to 2028 (US$ Million)
9. Anti-Infectives Agents Market Analysis and Forecast to 2028 - Route of Administration
9.1 Overview
9.2 Global Anti-Infectives Agents Market, by Route of Administration, 2022 & 2028 (%)
9.3 IV
9.3.1 Overview
9.3.2 IV Market Revenue and Forecast to 2028 (US$ Million)
9.4 Oral
9.4.1 Overview
9.4.2 Oral Market Revenue and Forecast to 2028 (US$ Million)
9.5 Topical
9.5.1 Overview
9.5.2 Topical Market Revenue and Forecast to 2028 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others Market Revenue and Forecast to 2028 (US$ Million)
10. Anti-Infectives Agents Market Analysis and Forecast to 2028 - Indication
10.1 Overview
10.2 Global Anti-Infectives Agents Market, by Indication, 2022 & 2028 (%)
10.3 HIV
10.3.1 Overview
10.3.2 HIV Market Revenue and Forecast to 2028 (US$ Million)
10.4 Tuberculosis
10.4.1 Overview
10.4.2 Tuberculosis Market Revenue and Forecast to 2028 (US$ Million)
10.5 Respiratory Infection
10.5.1 Overview
10.5.2 Respiratory Infection Market Revenue and Forecast to 2028 (US$ Million)
10.6 Pneumonia
10.6.1 Overview
10.6.2 Pneumonia Market Revenue and Forecast to 2028 (US$ Million)
10.7 Others
10.7.1 Overview
10.7.2 Others Market Revenue and Forecast to 2028 (US$ Million)
11. Anti-Infectives Agents Market Analysis and Forecast to 2028 - Distribution Channel
11.1 Overview
11.2 Global Anti-Infectives Agents Market, by Distribution Channel, 2022 & 2028 (%)
11.3 Hospital Pharmacies
11.3.1 Overview
11.3.2 Hospital Pharmacies Market Revenue and Forecast to 2028 (US$ Million)
11.4 Retail Pharmacies
11.4.1 Overview
11.4.2 Retail Pharmacies Market Revenue and Forecast to 2028 (US$ Million)
11.5 Specialty Pharmacies
11.5.1 Overview
11.5.2 Specialty Pharmacies Market Revenue and Forecast to 2028 (US$ Million)
11.6 E-Commerce
11.6.1 Overview
11.6.2 E-Commerce Market Revenue and Forecast to 2028 (US$ Million)
11.7 Others
11.7.1 Overview
11.7.2 Others Market Revenue and Forecast to 2028 (US$ Million)
12. Anti-Infectives Agents Market Analysis and Forecasts To 2028 - Geographical Analysis
12.1 North America Anti-infectives Agents Market Revenue and Forecasts To 2028
12.1.1 Overview
12.1.2 North America: Anti-Infective Agents Market - Revenue and Forecast to 2028 (US$ Million)
12.1.3 North America: Anti-Infective Agents Market, by Type, 2019-2028 (US$ Million)
12.1.4 North America: Anti-Infective Agents Market, by Range, 2019-2028 (US$ Million)
12.1.5 North America: Anti-Infective Agents Market, by Route of Administration, 2019-2028 (US$ Million)
12.1.6 North America: Anti-Infective Agents Market, by Indications, 2019-2028 (US$ Million)
12.1.7 North America: Anti-Infective Agents Market, by Distribution Channel, 2019-2028 (US$ Million)
12.1.8 North America: Anti-Infective Agents Market, by Country, 2022 & 2028 (%)
12.1.8.1 US: Anti-Infective Agents Market - Revenue and Forecast to 2028 (US$ Million)
12.1.8.1.1 Overview
12.1.8.1.2 US: Anti-Infective Agents Market - Revenue and Forecast to 2028 (US$ Million)
12.1.8.1.3 US: Anti-Infective Agents Market, by Type, 2019-2028 (US$ Million)
12.1.8.1.4 US: Anti-Infective Agents Market, by Range, 2019-2028 (US$ Million)
12.1.8.1.5 US: Anti-Infective Agents Market, by Route of Administration, 2019-2028 (US$ Million)
12.1.8.1.6 US: Anti-Infective Agents Market, by Indications, 2019-2028 (US$ Million)
12.1.8.1.7 US: Anti-Infective Agents Market, by Distribution Channel, 2019-2028 (US$ Million)
12.1.8.2 Canada: Anti-Infective Agents Market - Revenue and Forecast to 2028 (US$ Million)
12.1.8.2.1 Overview
12.1.8.2.2 Canada: Anti-Infective Agents Market - Revenue and Forecast to 2028 (US$ Million)
12.1.8.2.3 Canada: Anti-Infective Agents Market, by Type, 2019-2028 (US$ Million)
12.1.8.2.4 Canada: Anti-Infective Agents Market, by Range, 2019-2028 (US$ Million)
12.1.8.2.5 Canada: Anti-Infective Agents Market, by Route of Administration, 2019-2028 (US$ Million)
12.1.8.2.6 Canada: Anti-Infective Agents Market, by Indications, 2019-2028 (US$ Million)
12.1.8.2.7 Canada: Anti-Infective Agents Market, by Distribution Channel, 2019-2028 (US$ Million)
12.1.8.3 Mexico: Anti-Infective Agents Market - Revenue and Forecast to 2028 (US$ Million)
12.1.8.3.1 Overview
12.1.8.3.2 Mexico: Anti-Infective Agents Market - Revenue and Forecast to 2028 (US$ Million)
12.1.8.3.3 Mexico: Anti-Infective Agents Market, by Type, 2019-2028 (US$ Million)
12.1.8.3.4 Mexico: Anti-Infective Agents Market, by Range, 2019-2028 (US$ Million)
12.1.8.3.5 Mexico: Anti-Infective Agents Market, by Route of Administration, 2019-2028 (US$ Million)
12.1.8.3.6 Mexico: Anti-Infective Agents Market, by Indications, 2019-2028 (US$ Million)
12.1.8.3.7 Mexico: Anti-Infective Agents Market, by Distribution Channel, 2019-2028 (US$ Million)
12.2 Europe: Anti-infectives Agents Market
12.2.1 Overview
12.2.2 Europe: Anti-Infectives Agents Market - Revenue and Forecast to 2028 (US$ Million)
12.2.3 Europe: Anti-infectives Agents Market, by Type, 2019-2028 (US$ Million)
12.2.4 Europe: Anti-infectives Agents Market, by Range, 2019-2028 (US$ Million)
12.2.5 Europe: Anti-infectives Agents Market, by Route of Administration, 2019-2028 (US$ Million)
12.2.6 Europe: Anti-infectives Agents Market, by Indication, 2019-2028 (US$ Million)
12.2.7 Europe: Anti-infectives Agents Market, by Distribution Channel, 2019-2028 (US$ Million)
12.2.8 Europe: Anti-Infectives Agents Market, by Country, 2022 & 2028 (%)
12.2.8.1 Germany: Anti-Infectives Agents Market - Revenue and Forecast to 2028 (US$ Million)
12.2.8.1.1 Overview
12.2.8.1.2 Germany: Anti-Infectives Agents Market - Revenue and Forecast to 2028 (US$ Million)
12.2.8.1.3 Germany: Anti-infectives Agents Market, by Type, 2019-2028 (US$ Million)
12.2.8.1.4 Germany: Anti-infectives Agents Market, by Range, 2019-2028 (US$ Million)
12.2.8.1.5 Germany: Anti-infectives Agents Market, by Route of Administration, 2019-2028 (US$ Million)
12.2.8.1.6 Germany: Anti-infectives Agents Market, by Indication, 2019-2028 (US$ Million)
12.2.8.1.7 Germany: Anti-infectives Agents Market, by Distribution Channel, 2019-2028 (US$ Million)
12.2.8.2 UK: Anti-Infectives Agents Market - Revenue and Forecast to 2028 (US$ Million)
12.2.8.2.1 Overview
12.2.8.2.2 UK: Anti-Infectives Agents Market - Revenue and Forecast to 2028 (US$ Million)
12.2.8.2.3 UK: Anti-infectives Agents Market, by Type, 2019-2028 (US$ Million)
12.2.8.2.4 UK: Anti-infectives Agents Market, by Range, 2019-2028 (US$ Million)
12.2.8.2.5 UK: Anti-infectives Agents Market, by Route of Administration, 2019-2028 (US$ Million)
12.2.8.2.6 UK: Anti-infectives Agents Market, by Indication, 2019-2028 (US$ Million)
12.2.8.2.7 UK: Anti-infectives Agents Market, by Distribution Channel, 2019-2028 (US$ Million)
12.2.8.3 France: Anti-Infectives Agents Market - Revenue and Forecast to 2028 (US$ Million)
12.2.8.3.1 Overview
12.2.8.3.2 France: Anti-Infectives Agents Market - Revenue and Forecast to 2028 (US$ Million)
12.2.8.3.3 France: Anti-infectives Agents Market, by Type, 2019-2028 (US$ Million)
12.2.8.3.4 France: Anti-infectives Agents Market, by Range, 2019-2028 (US$ Million)
12.2.8.3.5 France: Anti-infectives Agents Market, by Route of Administration, 2019-2028 (US$ Million)
12.2.8.3.6 France: Anti-infectives Agents Market, by Indication, 2019-2028 (US$ Million)
12.2.8.3.7 France: Anti-infectives Agents Market, by Distribution Channel, 2019-2028 (US$ Million)
12.2.8.4 Italy: Anti-Infectives Agents Market - Revenue and Forecast to 2028 (US$ Million)
12.2.8.4.1 Overview
12.2.8.4.2 Italy: Anti-Infectives Agents Market - Revenue and Forecast to 2028 (US$ Million)
12.2.8.4.3 Italy: Anti-Infectives Agents Market, by Type, 2019-2028 (US$ Million)
12.2.8.4.4 Italy: Anti-Infectives Agents Market, by Range, 2019-2028 (US$ Million)
12.2.8.4.5 Italy: Anti-Infectives Agents Market, by Route of Administration, 2019-2028 (US$ Million)
12.2.8.4.6 Italy: Anti-Infectives Agents Market, by Indication, 2019-2028 (US$ Million)
12.2.8.4.7 Italy: Anti-Infectives Agents Market, by Distribution Channel, 2019-2028 (US$ Million)
12.2.8.5 Spain: Anti-Infectives Agents Market - Revenue and Forecast to 2028 (US$ Million)
12.2.8.5.1 Overview
12.2.8.5.2 Spain: Anti-Infectives Agents Market - Revenue and Forecast to 2028 (US$ Million)
12.2.8.5.3 Spain: Anti-Infectives Agents Market, by Type, 2019-2028 (US$ Million)
12.2.8.5.4 Spain: Anti-Infectives Agents Market, by Range, 2019-2028 (US$ Million)
12.2.8.5.5 Spain: Anti-Infectives Agents Market, by Route of Administration, 2019-2028 (US$ Million)
12.2.8.5.6 Spain: Anti-Infectives Agents Market, by Indication, 2019-2028 (US$ Million)
12.2.8.5.7 Spain: Anti-Infectives Agents Market, by Distribution Channel, 2019-2028 (US$ Million)
12.2.8.6 Rest of Europe: Anti-Infectives Agents Market - Revenue and Forecast to 2028 (US$ Million)
12.2.8.6.1 Overview
12.2.8.6.2 Rest of Europe: Anti-Infectives Agents Market - Revenue and Forecast to 2028 (US$ Million)
12.2.8.6.3 Rest of Europe: Anti-infectives Agents Market, by Type, 2019-2028 (US$ Million)
12.2.8.6.4 Rest of Europe: Anti-infectives Agents Market, by Range, 2019-2028 (US$ Million)
12.2.8.6.5 Rest of Europe: Anti-infectives Agents Market, by Route of Administration, 2019-2028 (US$ Million)
12.2.8.6.6 Rest of Europe: Anti-infectives Agents Market, by Indication, 2019-2028 (US$ Million)
12.2.8.6.7 Rest of Europe: Anti-infectives Agents Market, by Distribution Channel, 2019-2028 (US$ Million)
12.3 Asia Pacific: Anti-infective agents Market
12.3.1 Overview
12.3.2 Asia Pacific: Anti-infective agents Market - Revenue and Forecast to 2028 (US$ Million)
12.3.3 Asia Pacific: Anti-infective agents Market, by Type, 2019-2028 (US$ Million)
12.3.4 Asia Pacific: Anti-infective agents Market, by Range, 2019-2028 (US$ Million)
12.3.5 Asia Pacific: Anti-infective agents Market, by Route of Administration, 2019-2028 (US$ Million)
12.3.6 Asia Pacific: Anti-infective agents Market, by Indication, 2019-2028 (US$ Million)
12.3.7 Asia Pacific: Anti-infective agents Market, by Distribution Channel, 2019-2028 (US$ Million)
12.3.8 Asia Pacific: Anti-infective agents Market, by Country, 2022 & 2028 (%)
12.3.8.1 China: Anti-infective agents Market - Revenue and Forecast to 2028 (US$ Million)
12.3.8.1.1 China: Anti-infective agents Market - Revenue and Forecast to 2028 (US$ Million)
12.3.8.1.2 China: Anti-infective agents Market, by Type, 2019-2028 (US$ Million)
12.3.8.1.3 China: Anti-infective agents Market, by Range, 2019-2028 (US$ Million)
12.3.8.1.4 China: Anti-infective agents Market, by Route of Administration, 2019-2028 (USD Million)
12.3.8.1.5 China: Anti-infective agents Market, by Indication, 2019-2028 (USD Million)
12.3.8.1.6 China: Anti-infective agents Market, by Distribution Channel, 2019-2028 (USD Million)
12.3.8.2 Japan: Anti-infective agents Market - Revenue and Forecast to 2028 (USD Million)
12.3.8.2.1 Japan: Anti-infective agents Market - Revenue and Forecast to 2028 (USD Million)
12.3.8.2.2 Japan: Anti-infective agents Market, by Type, 2019-2028 (USD Million)
12.3.8.2.3 Japan: Anti-infective agents Market, by Range, 2019-2028 (USD Million)
12.3.8.2.4 Japan: Anti-infective agents Market, by Route of Administration, 2019-2028 (USD Million)
12.3.8.2.5 Japan: Anti-infective agents Market, by Indication, 2019-2028 (USD Million)
12.3.8.2.6 Japan: Anti-infective agents Market, by Distribution Channel, 2019-2028 (USD Million)
12.3.8.3 India: Anti-infective agents Market - Revenue and Forecast to 2028 (USD Million)
12.3.8.3.1 India: Anti-infective agents Market - Revenue and Forecast to 2028 (USD Million)
12.3.8.3.2 India: Anti-infective agents Market, by Type, 2019-2028 (USD Million)
12.3.8.3.3 India: Anti-infective agents Market, by Range, 2019-2028 (USD Million)
12.3.8.3.4 India: Anti-infective agents Market, by Route of Administration, 2019-2028 (USD Million)
12.3.8.3.5 India: Anti-infective agents Market, by Indication, 2019-2028 (USD Million)
12.3.8.3.6 India: Anti-infective agents Market, by Distribution Channel, 2019-2028 (USD Million)
12.3.8.4 South Korea: Anti-infective agents Market - Revenue and Forecast to 2028 (USD Million)
12.3.8.4.1 South Korea: Anti-infective agents Market - Revenue and Forecast to 2028 (USD Million)
12.3.8.4.2 South Korea: Anti-infective agents Market, by Type, 2019-2028 (USD Million)
12.3.8.4.3 South Korea: Anti-infective agents Market, by Range, 2019-2028 (USD Million)
12.3.8.4.4 South Korea: Anti-infective agents Market, by Route of Administration, 2019-2028 (USD Million)
12.3.8.4.5 South Korea: Anti-infective agents Market, by Indication, 2019-2028 (USD Million)
12.3.8.4.6 South Korea: Anti-infective agents Market, by Distribution Channel, 2019-2028 (USD Million)
12.3.8.5 Australia: Anti-infective agents Market - Revenue and Forecast to 2028 (USD Million)
12.3.8.5.1 Australia: Anti-infective agents Market - Revenue and Forecast to 2028 (USD Million)
12.3.8.5.2 Australia: Anti-infective agents Market, by Type, 2019-2028 (USD Million)
12.3.8.5.3 Australia: Anti-infective agents Market, by Range, 2019-2028 (USD Million)
12.3.8.5.4 Australia: Anti-infective agents Market, by Route of Administration, 2019-2028 (USD Million)
12.3.8.5.5 Australia: Anti-infective agents Market, by Indication, 2019-2028 (USD Million)
12.3.8.5.6 Australia: Anti-infective agents Market, by Distribution Channel, 2019-2028 (USD Million)
12.3.8.6 Rest of Asia Pacific: Anti-infective agents Market - Revenue and Forecast to 2028 (USD Million)
12.3.8.6.1 Rest of Asia Pacific: Anti-infective agents Market - Revenue and Forecast to 2028 (USD Million)
12.3.8.6.2 Rest of Asia Pacific: Anti-infective agents Market, by Type, 2019-2028 (USD Million)
12.3.8.6.3 Rest of Asia Pacific: Anti-infective agents Market, by Range, 2019-2028 (USD Million)
12.3.8.6.4 Rest of Asia Pacific: Anti-infective agents Market, by Route of Administration, 2019-2028 (USD Million)
12.3.8.6.5 Rest of Asia Pacific: Anti-infective agents Market, by Indication, 2019-2028 (USD Million)
12.3.8.6.6 Rest of Asia Pacific: Anti-infective agents Market, by Distribution Channel, 2019-2028 (USD Million)
12.4 Middle East & Africa: Anti-infective agents Market
12.4.1 Overview
12.4.2 Middle East & Africa: Anti-infective agents Market - Revenue and Forecast to 2028 (US$ Million)
12.4.3 Middle East & Africa: Anti-infective agents Market, by Type, 2019-2028 (USD Million)
12.4.4 Middle East & Africa Anti-infective agents Market, by Range - Revenue and Forecast to 2028 (USD Million)
12.4.5 Middle East & Africa Anti-infective agents Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
12.4.6 Middle East & Africa Anti-infective agents Market, by Indication - Revenue and Forecast to 2028 (USD Million)
12.4.7 Middle East & Africa Anti-infective agents Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
12.4.8 Middle East & Africa: Anti-infective agents Market, by Country, 2022 & 2028 (%)
12.4.8.1 Saudi Arabia: Anti-infective agents Market - Revenue and Forecast to 2028 (USD Million)
12.4.8.1.1 Saudi Arabia: Anti-infective agents Market - Revenue and Forecast to 2028 (USD Million)
12.4.8.1.2 Saudi Arabia: Anti-infective agents Market, by Type, 2019-2028 (USD Million)
12.4.8.1.3 Saudi Arabia Anti-infective agents Market, by Range - Revenue and Forecast to 2028 (USD Million)
12.4.8.1.4 Saudi Arabia Anti-infective agents Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
12.4.8.1.5 Saudi Arabia Anti-infective agents Market, by Indication - Revenue and Forecast to 2028 (USD Million)
12.4.8.1.6 Saudi Arabia Anti-infective agents Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
12.4.8.2 UAE: Anti-infective agents Market - Revenue and Forecast to 2028 (USD Million)
12.4.8.2.1 UAE: Anti-infective agents Market - Revenue and Forecast to 2028 (USD Million)
12.4.8.2.2 UAE: Anti-infective agents Market, by Type, 2019-2028 (USD Million)
12.4.8.2.3 UAE Anti-infective agents Market, by Range - Revenue and Forecast to 2028 (USD Million)
12.4.8.2.4 UAE Anti-infective agents Market, by Route of Application - Revenue and Forecast to 2028 (USD Million)
12.4.8.2.5 UAE Anti-infective agents Market, by Indication - Revenue and Forecast to 2028 (USD Million)
12.4.8.2.6 UAE Anti-infective agents Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
12.4.8.3 South Africa: Anti-infective agents Market - Revenue and Forecast to 2028 (USD Million)
12.4.8.3.1 South Africa: Anti-infective agents Market - Revenue and Forecast to 2028 (USD Million)
12.4.8.3.2 South Africa: Anti-infective agents Market, by Type, 2019-2028 (USD Million)
12.4.8.3.3 South Africa Anti-infective agents Market, by Range - Revenue and Forecast to 2028 (USD Million)
12.4.8.3.4 South Africa Anti-infective agents Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
12.4.8.3.5 South Africa Anti-infective agents Market, by Indication - Revenue and Forecast to 2028 (USD Million)
12.4.8.3.6 South Africa Anti-infective agents Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
12.4.8.4 Rest of Middle East & Africa: Anti-infective agents Market - Revenue and Forecast to 2028 (USD Million)
12.4.8.4.1 Rest of Middle East & Africa: Anti-infective agents Market - Revenue and Forecast to 2028 (USD Million)
12.4.8.4.2 Rest of Middle East & Africa: Anti-infective agents Market, by Type, 2019-2028 (USD Million)
12.4.8.4.3 Rest of Middle East & Africa: Anti-infective agents Market, by Range, 2019-2028 (USD Million)
12.4.8.4.4 Rest of Middle East & Africa: Anti-infective agents Market, by Route of Administration, 2019-2028 (USD Million)
12.4.8.4.5 Rest of Middle East & Africa: Anti-infective agents Market, by Indication, 2019-2028 (USD Million)
12.4.8.4.6 Rest of Middle East & Africa: Anti-infective agents Market, by Distribution Channel, 2019-2028 (USD Million)
12.5 South and Central America Anti-Infective Agents Market
12.5.1 Overview
12.5.2 South and Central America Anti-Infective Agents Market Revenue and Forecast to 2028 (US$ Million)
12.5.3 South and Central America: Anti-Infectives Agents Market, by Type, 2019-2028 (US$ Million)
12.5.4 South and Central America: Anti-Infectives Agents Market, by Range, 2019-2028 (US$ Million)
12.5.5 South and Central America: Anti-Infectives Agents Market, by Route of Administration, 2019-2028 (US$ Million)
12.5.6 South and Central America: Anti-Infectives Agents Market, by Indication, 2019-2028 (US$ Million)
12.5.7 South and Central America: Anti-Infectives Agents Market, by Distribution Channel, 2019-2028 (US$ Million)
12.5.8 South and Central America Anti-Infective Agents Market Revenue and Forecast to 2028, by Country (%)
12.5.8.1 Brazil: Anti-Infective Agents Market - Revenue and Forecast to 2028 (USD Million)
12.5.8.1.1 Overview
12.5.8.1.2 Brazil Anti-Infective Agents Market Revenue and Forecast to 2028 (US$ Million)
12.5.8.1.3 Brazil: Anti-Infectives Agents Market, by Type, 2019-2028 (US$ Million)
12.5.8.1.4 Brazil: Anti-Infectives Agents Market, by Range, 2019-2028 (US$ Million)
12.5.8.1.5 Brazil: Anti-Infectives Agents Market, by Route of Administration, 2019-2028 (US$ Million)
12.5.8.1.6 Brazil: Anti-Infectives Agents Market, by Indication, 2019-2028 (US$ Million)
12.5.8.1.7 Brazil: Anti-Infectives Agents Market, by Distribution Channel, 2019-2028 (US$ Million)
12.5.8.2 Argentina: Anti-Infective Agents Market - Revenue and Forecast to 2028 (USD Million)
12.5.8.2.1 Overview
12.5.8.2.2 Argentina Anti-Infective Agents Market Revenue and Forecast to 2028 (US$ Million)
12.5.8.2.3 Argentina: Anti-infectives Agents Market, by Type, 2019-2028 (US$ Million)
12.5.8.2.4 Argentina: Anti-infectives Agents Market, by Range, 2019-2028 (US$ Million)
12.5.8.2.5 Argentina: Anti-infectives Agents Market, by Route of Administration, 2019-2028 (US$ Million)
12.5.8.2.6 Argentina: Anti-infectives Agents Market, by Indication, 2019-2028 (US$ Million)
12.5.8.2.7 Argentina: Anti-infectives Agents Market, by Distribution Channel, 2019-2028 (US$ Million)
12.5.8.3 Rest of the South and Central America: Anti-Infective Agents Market - Revenue and Forecast to 2028 (USD Million)
12.5.8.3.1 Overview
12.5.8.3.2 Rest of the South and Central America Anti-Infective Agents Market Revenue and Forecast to 2028 (US$ Million)
12.5.8.3.3 Rest of the South and Central America: Anti-Infectives Agents Market, by Type, 2019-2028 (US$ Million)
12.5.8.3.4 Rest of the South and Central America: Anti-Infectives Agents Market, by Range, 2019-2028 (US$ Million)
12.5.8.3.5 Rest of the South and Central America: Anti-Infectives Agents Market, by Route of Administration, 2019-2028 (US$ Million)
12.5.8.3.6 Rest of the South and Central America: Anti-Infectives Agents Market, by Indication, 2019-2028 (US$ Million)
12.5.8.3.7 Rest of the South and Central America: Anti-Infectives Agents Market, by Distribution Channel, 2019-2028 (US$ Million)
13. Impact of COVID-19 Pandemic on Global Anti-Infectives Agents Market
13.1 North America: Impact Assessment of COVID-19 Pandemic
13.2 Europe: Impact Assessment of COVID-19 Pandemic
13.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
13.4 Middle East & Africa: Impact Assessment of COVID-19 Pandemic
13.5 South and Central America: Impact Assessment of COVID-19 Pandemic
14. Anti-infectives Agents Market-Industry Landscape
14.1 Overview
14.2 Growth Strategies In The Anti-infective agents Market, 2018-2022
14.3 Organic Developments
14.3.1 Overview
14.3.2 Organic Growth Strategies In The Anti-infective agents Market, 2018-2022
14.4 Inorganic Developments
14.4.1 Overview
14.4.2 Inorganic Growth Strategies In The Anti-infective agents Market, 2018-2022
15. Anti-Infectives Agents Market- Company Profiles
15.1 Abbott
15.1.1 Key Facts
15.1.2 Business Description
15.1.3 Products and Services
15.1.4 Financial Overview
15.1.5 SWOT Analysis
15.1.6 Key Developments
15.2 Allergan Plc.
15.2.1 Key Facts
15.2.2 Business Description
15.2.3 Products and Services
15.2.4 Financial Overview
15.2.5 SWOT Analysis
15.2.6 Key Developments
15.3 Astellas Pharma Inc.
15.3.1 Key Facts
15.3.2 Business Description
15.3.3 Products and Services
15.3.4 Financial Overview
15.3.5 SWOT Analysis
15.3.6 Key Developments
15.4 Merck & Co., Inc.
15.4.1 Key Facts
15.4.2 Business Description
15.4.3 Products and Services
15.4.4 Financial Overview
15.4.5 SWOT Analysis
15.4.6 Key Developments
15.5 Bayer AG
15.5.1 Key Facts
15.5.2 Business Description
15.5.3 Products and Services
15.5.4 Financial Overview
15.5.5 SWOT Analysis
15.5.6 Key Developments
15.6 Bristol-Myers Squibb Company
15.6.1 Key Facts
15.6.2 Business Description
15.6.3 Products and Services
15.6.4 Financial Overview
15.6.5 SWOT Analysis
15.6.6 Key Developments
15.7 Boehringer Ingelheim International GmbH
15.7.1 Key Facts
15.7.2 Business Description
15.7.3 Products and Services
15.7.4 Financial Overview
15.7.5 SWOT Analysis
15.7.6 Key Developments
15.8 F. HOFFMANN-LA ROCHE LTD.
15.8.1 Key Facts
15.8.2 Business Description
15.8.3 Products and Services
15.8.4 Financial Overview
15.8.5 SWOT Analysis
15.8.6 Key Developments
15.9 Gilead Sciences, Inc.
15.9.1 Key Facts
15.9.2 Business Description
15.9.3 Products and Services
15.9.4 Financial Overview
15.9.5 SWOT Analysis
15.9.6 Key Developments
15.10 GlaxoSmithKline plc.
15.10.1 Key Facts
15.10.2 Business Description
15.10.3 Products and Services
15.10.4 Financial Overview
15.10.5 SWOT Analysis
15.10.6 Key Developments
15.11 Novartis AG
15.11.1 Key Facts
15.11.2 Business Description
15.11.3 Products and Services
15.11.4 Financial Overview
15.11.5 SWOT Analysis
15.11.6 Key Developments
16. Appendix
16.1 About the Publisher
16.2 Glossary of Terms

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Abbott
  • Allergan Plc.
  • Astellas Pharma Inc.
  • Merck & Co., Inc.
  • Bayer AG
  • Bristol-Myers Squibb Company
  • Boehringer Ingelheim International GmbH
  • F. Hoffmann-La Roche Ltd.
  • Gilead Sciences, Inc.
  • GlaxoSmithKline plc.
  • Novartis AG